GILD

GILEAD SCIENCES, INC.

Health Care · Biotechnology

$238.70 sample

-2.18 (-0.91%) 1D

Market cap

$416.4B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-06

Alerts

8

Price$238.70 -6.69% 3M daily closessample

258.13235.25

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 06SECDEF 14A filed
Sep 30INSInsider sell: 10% owner
Sep 21SECForm 144 filed
Sep 15INSInsider sell: Chief Executive Officer
Sep 10INSInsider sell: Chief Financial Officer
Sep 01INSInsider buy: Chief Executive Officer
Aug 24SEC8-K filed: material event
Aug 18INSInsider sell: General Counsel

Sign up to see the real GILD record →

Company facts

SEC EDGAR registration

Name: GILEAD SCIENCES, INC.
Sector: Health Care
Industry: Biotechnology
Smart-money score: -54sample, -100 to +100
Reporting currency: USD

Who is positioning in GILD

sample

Insiders: 33 insider transactions over 90 days, net selling, $188.1M
Congress: 3 members traded over 90 days
Institutions · 13F: 38 funds hold $9.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$23.4B +14.4% y/y

Q4 2024Q3 2026

Inventory$14.5B +17.2% y/y

Q4 2024Q3 2026

Accounts receivable$10.0B +5.2% y/y

Q4 2024Q3 2026

Total debt$27.3B +8.6% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $243.9B +3.6% 3M
Sample peer B: $257.9B +5.3% 3M
Sample peer C: $69.8B +9.7% 3M
Sample peer D: $327.8B +6.1% 3M
Sample peer E: $108.9B +11.9% 3M